UiPath Inc. (NYSE: PATH) shares are commanding a significant premium to Wall Street's consensus valuation as the automation software maker prepares to release its fiscal second-quarter results after Thursday's market close. Early Tuesday trading saw the stock slip 0.8% to $18.51, a level that stands 29.2% above the average analyst price target of $14.33, according to MarketBeat data compiled on September 1, 2026.
The premium underscores the market's optimism about UiPath's growth trajectory, particularly around its agentic automation offerings. However, it also raises the bar for the company's upcoming earnings report, as merely matching consensus estimates may not justify the elevated valuation. The stock has surged 42.2% over the past month, far outpacing the S&P 500's 3.9% gain during the same period.
Q2 Guidance Points to Sequential Revenue Decline
UiPath's management has guided for second-quarter revenue in the range of $395 million to $400 million, with a midpoint of $397.5 million. This aligns closely with the consensus estimate of $397.59 million, but represents a 5.0% sequential decline from the $418.4 million reported in the first quarter. The guidance also implies annualized renewal run-rate (ARR) of $1.929 billion to $1.934 billion, suggesting net additions of roughly $30.5 million—a slowdown from the $49 million added in Q1.
Non-GAAP operating income is projected at approximately $75 million for the quarter. The company ended the first quarter with $1.42 billion in cash and marketable securities, a GAAP gross margin of 82%, and adjusted free cash flow of $130 million.
Analyst Sentiment and Price Targets
The current analyst landscape reflects a cautious stance, with 14 hold ratings, two buys, and one sell among the 17 analysts covering the stock. Price targets range from a low of $12 to a high of $19, with the average sitting at $14.33. Notably, UBS raised its target from $12 to $19 on Monday, a level just 2.6% above Tuesday's early price—still far below the current trading level.
The wide dispersion in targets suggests that the market's recent rally has outpaced analysts' ability to adjust their models. The average target implies a potential 22.6% downside from current levels, a gap that could narrow if UiPath delivers stronger-than-expected results or raises its full-year guidance.
What to Watch on Thursday
While the revenue figure will be the initial headline, investors are expected to focus on more granular metrics. Net new ARR, retention rates, and any updates to the full-year ARR target of $2.058 billion to $2.063 billion will be critical. CEO Daniel Dines has highlighted that agentic products have transitioned "from pilot to production," a narrative that could support future growth if reflected in the numbers.
The earnings call, scheduled for 17:00 EDT, will provide management's outlook and color on customer demand. Given the stock's premium valuation, any signs of softening in renewals or increased competitive pressure from AI rivals could trigger a sharp correction.
UiPath's market value has climbed to roughly $9.4 billion, representing about 4.9 times its projected ARR. This multiple is at the higher end of the software sector, making the upcoming results a key test of whether the market's enthusiasm is justified.
